Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
Abstract Background In contrast to vitamin K antagonists (VKA), direct oral anticoagulants (DOAC's) are not strictly monitored and dose titrated by anticoagulation clinics in the Netherlands. This may affect drug persistence of atrial fibrillation (AF) patients, whom often require lifelong trea...
Guardado en:
Autores principales: | Gilda Denise Zielinski, Nienke vanRein, Martina Teichert, Frederikus A. Klok, Frits R. Rosendaal, Felix J. M. van derMeer, Menno V. Huisman, Suzanne C. Cannegieter, Willem M. Lijfering |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d1f8cadf9954cbc8c400b71defeab7b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
por: Turagam MK, et al.
Publicado: (2015) -
Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis
por: Eleonora Camilleri, et al.
Publicado: (2021) -
Direct oral anticoagulants; a review for the non-specialist
por: Thilina Gunawardena
Publicado: (2021) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
por: Victoria Speed, et al.
Publicado: (2021) -
Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Clara Bonanad, et al.
Publicado: (2021)